The Cohorts · Quarterly vintage
Inception 2024-07-01 · 2.2 years held
Q3 2024 · Top 5.
On 2024-07-01, these 5 businesses were the 5most-undervalued names in our coverage universe by Mr. Market's protocol. We've held them, equal-weighted, since.
Q3 2024 · Top 5 · since inception
+75.4%
CAGR 28.8% annualised
S&P 500 · since inception
+43.3%
CAGR 17.6% annualised
Spread
+32.1%
This cohort has beaten the index.
Other cohorts at the same inception
The constituents.
Ranked, on the inception date, by Δ% to intrinsic value. Each holding is equal-weighted at 20.0% of the portfolio.
| Rank | Ticker | Entry price | Entry IV | Entry Δ% | Current price | Return | Contribution | |
|---|---|---|---|---|---|---|---|---|
| 1 | JPM | $196.08 | $5,369.79 | +2638.6% | $349.67 | +78.3% | +15.7% | Read → |
| 2 | BAC | $38.03 | $349.95 | +820.3% | $57.73 | +51.8% | +10.4% | Read → |
| 3 | OXY | $60.15 | $416.91 | +593.2% | $58.84 | -2.2% | -0.4% | Read → |
| 4 | CAT | $319.76 | $1,909.53 | +497.2% | $808.99 | +153.0% | +30.6% | Read → |
| 5 | JNJ | $137.68 | $708.75 | +414.8% | $269.99 | +96.1% | +19.2% | Read → |
Biggest contributors
Where the cohort earned its keep.
- CAT · $319.76 → $808.99+153.0%
- JNJ · $137.68 → $269.99+96.1%
- JPM · $196.08 → $349.67+78.3%
Biggest detractors
Where the protocol got it wrong.
- OXY · $60.15 → $58.84-2.2%